Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clearing heat and promoting blood flow for active rheumatoid arthritis
ChiCTR-TRC-09000377Phase 4Completed
- Sponsor
- Guang'anmen Hospital
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methotrexate in rheumatoid arthritis (RA) (3 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Criteria for therapeutic effects and Evaluation of therapeutic effect on TCM syndrome. Started Jul 2007; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-09000377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000377.